Oral

Z30.0/Z30.4


Dual contraception with barrier methods, are recommended to reduce the risk of STIs, including HIV.

Monophasic preparations:

  • Progestin only pills, e.g.:
  • Levonorgestrel, oral, 30mcg daily.

LoEIII [16]

  • Progestins and estrogen, fixed combinations, e.g.:
  • Ethinylestradiol/ levonorgestrel, oral, 30 mcg/150 mcg:
    • 21 tablets ethinylestradiol/levonorgestrel, 30 mcg/150 mcg and
    • 7 tablets placebo.

LoEIII [17]

Triphasic preparations:

  • Progestins and estrogen, sequential preparations, e.g.:
  • Ethinylestradiol/levonorgestrel, oral:
    • 6 tablets ethinylestradiol/levonorgestrel,30 mcg/50 mcg
    • 5 tablets ethinylestradiol/levonorgestrel, 40 mcg/75 mcg and
    • 10 tablets ethinylestradiol/levonorgestrel,30 mcg/125 mcg and
    • 7 tablets placebo.

LoEIII [18]

Counselling:

  • Hormonal oral pills must be taken at the same time every day without interruption.
  • Taking the hormonal oral pill with food or at bedtime may alleviate nausea.
  • If the woman is not using dual contraception with barrier methods and vomits within 2 hours, or has severe diarrhoea within 12 hours of taking the hormonal oral pill, repeat the dose as soon as possible. Recommend condom use.
  • Women who have persistent vomiting or severe diarrhoea resulting in two or more missed pills must follow instructions for missed pills. See Recommend the use of condoms.

Contraindications and guidance to starting the hormonal oral pill

Progestin only Combined estrogen/progestin
Contraindications Progestin only preparations
are contraindicated in certain
conditions. (Consult the package
insert in this regard).

Contraindications include:
» Abnormal uterine bleeding
of unknown cause.
» Myocardial infarction/ stroke

» Liver disease.
» Cancer of the breast or
genital tract
» Known or suspected
pregnancy. LoEIII[19]
Combination preparations
contraindicated in certain
conditions. (Consult the package
insert in this regard).

Contraindications include:
» Women >35 years of age who
smoke ≥ 15 cigarettes a day or
have risk factors for cardiovascular
disease:
- heart disease
- liver disease
- thromboembolism
- certain cancers
When to start the pill » Exclude pregnancy.
» Start anytime within the menstrual
cycle, but it is advisable to start during
menses.
» If the first pill is given between days 1
and 5 of the menstrual cycle the contraceptive
effect is achieved immediately.
» If the pill is started in
at any other time, it needs to be taken for at least 7 days before it protects against pregnancy.
» Start anytime within the menstrual
cycle, but it is advisable to start during
menses.
» If the first pill is given between days 1
and 5 of the menstrual cycle the contraceptive
effect is achieved immediately.
» Dual contraception use is recommended
irrespective of when the pill is started in
the menstrual cycle.

LoEIII [19]

Medicine interactions

Enzyme-inducing medicines interacting
with oral contraceptives
Recommendation
Therapeutic class Examples
Anti-tuberculosis Rifampicin Use copper IUCD or alternatively use dual
contraception e.g. condoms in
combination with COCs.
Anti-epileptics Phenobarbital Use IUCD or alternatively use dual
contraception e.g. condoms in
combination with COCs.
Phenytoin Use IUCD or alternatively use dual
contraception e.g. condoms in
combination with COCs.
Carbamazepine Use IUCD or alternatively use dual
contraception e.g. condoms in
combination with COCs.
Antiretrovirals Nevirapine Use IUCD or alternatively use dual
contraception e.g. condoms in
combination with COCs.
Lopinavir/ritonavir Use IUCD or alternatively use dual
contraception e.g. condoms in
combination with COCs.
Efavirenz Use IUCD or alternatively use dual
contraception e.g. condoms in
combination with COCs.

Non-liver enzyme inducing medicines

Lamotrigine:

  • Lowering of contraceptive effect not expected.
  • Oral contraceptives may reduce lamotrigine concentration by 50%, increasing the risk of seizures. Consider alternative dual contraception method.

Breastfeeding

  • Women who are intending to breastfeed should delay initiation of COCs until cessation of breastfeeding or at 6 months postpartum, whichever occurs earlier.

REFERRAL

Abnormal vaginal bleeding for > 3 months.